Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. - Wikidata - wikimedia - TriplyDB

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

http://www.wikidata.org/entity/Q34955984

about

Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo The Effect of LC-MS Data Preprocessing Methods on the Selection of Plasma Biomarkers in Fed vs. Fasted Rats.Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function.Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration Plasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146 Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS techniques.Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis Effects of rice bran oil on the blood lipids profiles and insulin resistance in type 2 diabetes patients.Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations.Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.Alteration of mitochondrial function and insulin sensitivity in primary mouse skeletal muscle cells isolated from transgenic and knockout mice: role of ogg1.Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations.Lipidomics in nutrition and food research.Steatosis in the liver.Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease.Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury.Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.Metabolomics profiling to investigate the pharmacologic mechanisms of berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis.Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.Relationship between the lipidome, inflammatory markers and insulin resistance.Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity.Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose.Changes of Phospholipids in Fetal Liver of Mice Conceived by In Vitro Fertilization.Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance.Renoprotective effect of Zhenwu decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorder Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population Patterns of time since last meal revealed by sparse PCA in an observational LC–MS based metabolomics study

P2860

Q27322378-91A81D24-29CF-4467-AB99-2C7813FCF801 Q28727526-15517506-F2AC-4136-80CA-8A8841CB2EA5 Q30832925-A4F5338A-AC47-4C14-8CC9-4D07F1F9DF96 Q34358476-30C12793-FE92-4F89-A52C-00C72BBC27E9 Q34461400-9E061EB8-9247-490E-9189-987E033CE96E Q34553091-69219846-5E59-45C2-B276-A322E41ABF9A Q35025292-C1634B54-46A7-4865-BAAB-44C9ACA8877E Q35027582-A199EB61-B511-43A7-88DC-7C14F799AE84 Q35036444-FD63B36F-C84B-4D3D-A50A-09E9320EB0AC Q35123226-82C67060-5E4C-4549-9DA8-AD6FD4C70A59 Q35854385-2391F6AD-736D-4E32-9C7D-7D29CBF28718 Q35939383-EB676E99-AD25-4376-A5DA-83D15AB29B4B Q36082381-8E5E0C73-3757-4ED0-8001-25F592E33A02 Q36339534-DA53B11E-4ACB-4005-9FE3-156601EABE8E Q36788837-E07E020F-EB92-4B63-B008-FADF31113A16 Q37018519-55D61FD8-3409-4B33-9B59-C157C0D2D0D1 Q37324986-B904EE0A-1153-4315-AA35-F2878A73B2F1 Q38081867-CE66F7D3-79A5-4092-8F70-F26BE3F16461 Q38165140-D1DF11B3-DE68-4876-9872-5F3396DB695D Q38252517-27368F37-641D-41D8-884E-C2EB4C71802F Q38742072-9EF85ADE-2E22-4003-9A00-E67E11B7948E Q39288685-66238C17-656F-413D-B9D6-08CB710072E4 Q40314706-64AF5706-788A-4129-845E-E59CF61EE5E8 Q41252411-D547EE3A-AD7B-4F48-897C-B433C5BE71E2 Q46908112-DBCC2DCE-768F-4793-8163-5FEDF33DD260 Q48161638-E8AEC4D4-9E17-4D21-B4F5-C13B2F3BE8F4 Q48169384-3E585647-D77E-41B8-A71F-7CA23A74BB5A Q53794703-6D357161-D387-49EF-8E83-1298ACDE4F7D Q54328647-B678A1DC-F634-4E42-8339-3FC3B1AE7CAC Q55283829-B271C64C-986A-4328-B178-A3F0D5F290AD Q57050372-C5E1D067-AB7B-452F-BBBF-56878A8F743F Q57174314-445F2585-F447-4DCB-9C01-9A0314E523DE Q58871198-889F7812-57B7-47DD-BD71-C690D0F56E8B

P2860

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

http://www.wikidata.org/entity/Q34955984

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@ast

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@en

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@nl

type

label

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@ast

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@en

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@nl

prefLabel

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@ast

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@en

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@nl

P1433

Q34955984-F54FF9C3-1FC5-4DD9-A909-A85DA6A8C60E

P1476

Q34955984-3C5DA66C-84F5-4245-BA95-94DD3F02809B

P2093

Q34955984-00038F13-47DD-4CDC-8366-7974CDB23BAF

Q34955984-114411E5-F53E-4BCB-A943-EBC0761D38A0

Q34955984-11C55C03-18E9-4948-89A9-B2332831383E

Q34955984-2BEA27A5-731F-411A-87E4-5F37A410F672

Q34955984-30F1DCA3-2B27-4F16-9A8E-97A47E741F4B

Q34955984-582DDCFC-755F-42BF-813A-5F74C5C1F730

Q34955984-588176A2-DFEB-45F7-AAFE-A7AFE0CDAE8B

Q34955984-6E72D35C-2489-490A-8BC2-612BD97B442A

Q34955984-8D27A1D7-ECDC-4630-90F0-D62513A333EB

Q34955984-90657447-5C1E-4C90-A15D-FC4CDFC0A905

P2860

Q34955984-01F87038-36F6-4546-90C3-0821761755F9

Q34955984-06F3A59A-A116-4D66-8F21-5B020E2C3554

Q34955984-0737821C-E0F1-46A3-90DB-5202E1723C7F

Q34955984-1D99A4B0-908B-4F20-9FEA-638AAFC49DF1

Q34955984-22A483CF-4DF7-4973-9B62-087E20C94E0A

Q34955984-29969B6D-9E84-4A59-92F7-9558D21092AF

Q34955984-3302C672-1BCB-479E-B641-F5C9CD0CE8FA

Q34955984-33C5086C-BA59-4BF6-9563-7A2233EC506A

Q34955984-3559CEA7-2841-47F8-9287-E69189E5648E

Q34955984-3B1A2E6E-B6C7-4CA7-AC14-446AD2D643FD

P304

Q34955984-38E3070E-5F60-44AB-8F00-2DDDAEDBE738

P31

Q34955984-E07FD90D-8BB2-4764-B9A2-9527B97B2CA8

P356

Q34955984-D732D439-10A6-41FF-8945-D8FE92B14D9D

P433

Q34955984-7D08CF6F-8069-47B2-96CC-74E8C037B54A

P478

Q34955984-33A789A9-A8B5-4B1C-837D-5752D8ABCD09

P577

Q34955984-6A686DA2-5659-40AE-B9FA-69CE9869B43B

P698

Q34955984-639D482A-9A37-4780-ACED-4CA3678B2493

P921

Q34955984-924F87F3-ABCD-480C-B825-BA50E404399A

Q34955984-C142F4D8-0931-4480-B0C7-BAC1688D2706

P932

Q34955984-31B0B10D-BCEC-42A9-97EA-771ED3F387EE

P356

P1433

Journal of Lipid Research

P1476

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

@en

P2093

Hyae Gyeong Cheon

http://www.w3.org/2001/XMLSchema#string

Joong-Soo Han

http://www.w3.org/2001/XMLSchema#string

Jung Ran Kim

http://www.w3.org/2001/XMLSchema#string

Kun Wook Chung

http://www.w3.org/2001/XMLSchema#string

Mira Kang

http://www.w3.org/2001/XMLSchema#string

Myoung Sook Han

http://www.w3.org/2001/XMLSchema#string

Myung-Shik Lee

http://www.w3.org/2001/XMLSchema#string

Sang Dal Rhee

http://www.w3.org/2001/XMLSchema#string

Shin-Young Park

http://www.w3.org/2001/XMLSchema#string

Sun Young Park

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of free fatty acid-induced insulin resistance in humans

Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.

Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria

Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

A central role for JNK in obesity and insulin resistance

DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells.

Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation.

P304

1234-1246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M014787

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21447485

http://www.w3.org/2001/XMLSchema#string

P921

P932

3090244

http://www.w3.org/2001/XMLSchema#string